Safety of sorafenib therapy in elderly adults with advanced hepatocellular carcinoma.

Francini, Edoardo; Mazzaroppi, Silvia; Fiaschi, Anna I; Petrioli, Roberto; Laera, Letizia; Roviello, Giandomenico; Pira, Teresa; Pellicelli, Adriano M; Bianco, Vincenzo

Francini, Edoardo; Mazzaroppi, Silvia; Fiaschi, Anna I; Petrioli, Roberto; Laera, Letizia; Roviello, Giandomenico; Pira, Teresa; Pellicelli, Adriano M; Bianco, Vincenzo.

Affiliation

Francini E; Medical Oncology Unit, Policlinico Umberto I Hospital, University of Rome, Rome, Italy.

J Am Geriatr Soc ; 62(11): 2204-5, 2014 Nov.

Article in En | MEDLINE | ID: mdl-25413190

Subject(s)

Carcinoma, Hepatocellular/drug therapy; Liver Neoplasms/drug therapy; Niacinamide/analogs & derivatives; Phenylurea Compounds/adverse effects; Phenylurea Compounds/therapeutic use; Activities of Daily Living/classification; Adverse Drug Reaction Reporting Systems; Age Factors; Aged; Aged, 80 and over; Carcinoma, Hepatocellular/pathology; Cohort Studies; Dose-Response Relationship, Drug; Female; Humans; Liver Neoplasms/pathology; Male; Neoplasm Staging; Niacinamide/adverse effects; Niacinamide/therapeutic use; Sorafenib

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenylurea Compounds / Niacinamide / Carcinoma, Hepatocellular / Liver Neoplasms Type of study: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male Language: En Journal: J Am Geriatr Soc Year: 2014 Document type: Article Affiliation country: Italy Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google